Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Feb 26;100(8):e24803.
doi: 10.1097/MD.0000000000024803.

18F-FDG PET/CT imaging for aggressive melanotic schwannoma of the L3 spinal root: A case report

Affiliations
Case Reports

18F-FDG PET/CT imaging for aggressive melanotic schwannoma of the L3 spinal root: A case report

Xun-Ze Shen et al. Medicine (Baltimore). .

Abstract

Rationale: Melanotic schwannoma (MS) is an unusual variant of a nerve sheath neoplasm that accounts for less than 1% of all primary peripheral nerve sheath tumors. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) has unique value in detecting malignant MS lesions. To date, only 4 cases of MS with hepatic metastasis have been reported. Herein, we report the fifth case, which is the first reported patient with MS of Asian ethnicity with hepatic metastasis.

Patient concerns: A 29-year-old woman with a 1-day history of backache was admitted to our hospital. PET/CT showed a paravertebral heterogeneous soft tissue mass along the spinal nerve at the L2-L3 level with strong FDG uptake, and a nodule with increased FDG uptake in the lateral lobe of the left liver.

Diagnosis: A puncture biopsy of the L3 bony destruction and surrounding soft tissue mass was performed. The final diagnosis was spinal MS with hepatic metastasis.

Interventions: The patient underwent 6 courses of systemic chemotherapy.

Outcomes: The patient did not receive further treatment for half a year after the end of chemotherapy and recovered well.

Lessons: Unlike conventional schwannomas, which are completely benign, MS has an unpredictable prognosis. It is thought to have low malignant potential, and the malignant type tends to metastasize. FDG PET/CT has a unique and important value in the differential diagnosis of benign and malignant lesions, in detecting occult metastases, monitoring the treatment response, and assessing the prognosis of MS.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

Figure 1
Figure 1
(A). In PET/CT axial series, extraspinal tumor with strong FDG uptake from the spinal canal through the neural foramen was seen. (B). Three-dimensional PET/CT images show the accompanying bone destruction in the L3 vertebral body and its right adnexa.
Figure 2
Figure 2
(A). Metastatic hepatic nodule in left lateral lobe with increased FDG uptake on PET/CT, and SUVmax of about 2.98. (B). The delayed PET/CT imaging showed a further increase in SUVmax to 3.79, and the FDG retention index of this hepatic nodule was about 27.2%.
Figure 3
Figure 3
(A). The biopsy specimen showed a markedly pigmented tumor composed of spindle cells with hematoxylin and eosin staining (×100). (B). Cell block preparation from the biopsy specimen immunohistochemically stained with S100 protein (×100), showing positive tumor cells.

References

    1. Millar WG. A malignant melanotic tumor of ganglion cells arising from thoracic sympathetic ganglion. Pathol Bacteriol 1932;35:351–7.
    1. Solomon RA, Handler MS, Sedelli RV, et al. . Intramedullary melanotic schwannoma of cervicomedullary junction. Neurosurgery 1987;20:36–8. - PubMed
    1. Santaguida C, Sabbagh AJ, Guiot MC, et al. . Aggressive intramedullary melanotic schwannoma. Neurosurgery 2004;55:1430–4. - PubMed
    1. Zhang HY, Yang GH, Chen HJ, et al. . Clinicopathological, immunohistochemical, and ultrastructural study of 13 cases of melanotic schwannoma. Chin Med J 2005;118:1451–61. - PubMed
    1. Torres-Mora J, Dry S, Li X, et al. . Malignant melanotic schwannian tumor. A clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of “melanotic schwannoma”. Am J Surg Pathol 2014;38:94–105. - PubMed

Publication types

MeSH terms